Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Research article

Induction of IFNα or IL-12 depends on differentiation of THP-1 cells in dengue infections without and with antibody enhancement

Authors: Rong-Fu Chen, Lin Wang, Jiin-Tsuey Cheng, Kuender D Yang

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

Appropriate induction of the early Th1 cytokine IL-12 is a critical defense directed against viral infection. We have previously shown that different viruses elicited either IL-12 or IFNα dependent Th1 reactions. Using dengue-2 virus, we sought to explore how dengue-2 induced IL-12 or IFNα expression by monocytic and its derived dendritic cells.

Methods

We employed human monocytic cell line, THP-1, to investigate whether differentiation of monocytic cells is involved in the switch between IFNα and IL-12 induction. Flow cytometry, RT-PCR and ELISA were respectively used to determine cell differentiation, IL-12 and IFNα mRNA expression and protein production.

Results

THP-1, expressing CD123, which is a plasmacytoid dendritic cell marker, but not CD14, CD11b or CD11c revealed IFNα mRNA expression while stimulated by dengue-2. In contrast, PMA-induced THP-1 differentiation toward monocytic cells expressed CD11b+, and CD14+, but not CD123, and revealed exclusively IL-12 expression while stimulated by dengue-2. Further studies showed that CD123+ expressing THP-1 cells elicited higher IFNα expression in dose and time dependent induction after infection, and PMA-induced monocytic differentiation of THP-1 cells revealed IL-12 expression. Antibody-dependent enhancement of DEN-2 infection significantly suppressed the DEN-2 induced IL-12 p40 expression in monocytic differentiated THP-1 cells.

Conclusions

Clarification and modulation of the early Th1 reaction in different monocytic cells may change or prevent complication from dengue infection.
Appendix
Available only for authorised users
Literature
1.
2.
Thomas SJ, Strickman D, Vaughn DW: Dengue epidemiology: virus epidemiology, ecology, and emergence. Adv Virus Res. 2003, 61: 235-289.CrossRefPubMed
3.
WHO Expert Committee on Viral Haemorrhagic Fevers: Viral haemorrhagic fevers. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1985, 721: 5-126.
4.
Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martinez E, et al: Dengue: a continuing global threat. Nat Rev Microbiol. 2010, 8 (12 Suppl): S7-S16.CrossRefPubMedPubMedCentral
5.
Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV: Dengue and dengue haemorrhagic fever. Lancet. 1998, 352 (9132): 971-977. 10.1016/S0140-6736(97)12483-7.CrossRefPubMed
6.
7.
Butt N, Abbassi A, Munir SM, Ahmad SM, Sheikh QH: Haematological and biochemical indicators for the early diagnosis of dengue viral infection. J Coll Physicians Surg Pak. 2008, 18 (5): 282-285.PubMed
8.
Nimmannitya S: Clinical manifestations of dengue/dengue haemorrhagic fever. Monograph on dengue/dengue haemorrhagic fever. Edited by: Thongcharoen P. 1993, New Delhi: WHO-SEARO, 48-54.
9.
Burke DS, Nisalak A, Johnson DE, Scott RM: A prospective study of dengue infections in Bangkok. AmJTrop Med Hyg. 1988, 38 (1): 172-180.
10.
Halstead SB, Nimmannitya S, Cohen SN: Observations related to pathogenesis of dengue hemorrhagic fever IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med. 1970, 42 (5): 311-328.PubMedPubMedCentral
11.
Lipscomb MF, Masten BJ: Dendritic cells: immune regulators in health and disease. Physiol Rev. 2002, 82 (1): 97-130.CrossRefPubMed
12.
Mohamadzadeh M, Luftig R: Dendritic cells: In the forefront of immunopathogenesis and vaccine development - A review. J Immune Based Ther Vaccines. 2004, 2 (1): 1-10.1186/1476-8518-2-1.CrossRefPubMedPubMedCentral
13.
Sozzani S, Vermi W, Del Prete A, Facchetti F: Trafficking properties of plasmacytoid dendritic cells in health and disease. Trends Immunol. 2010, 31 (7): 270-277. 10.1016/j.it.2010.05.004.CrossRefPubMed
14.
Gee K, Guzzo C, Che Mat NF, Ma W, Kumar A: The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets. 2009, 8 (1): 40-52. 10.2174/187152809787582507.CrossRefPubMed
15.
Rajkovic I, Dragicevic A, Vasilijic S, Bozic B, Dzopalic T, Tomic S, Majstorovic I, Vucevic D, Djokic J, Balint B, et al: Differences in T-helper polarizing capability between human monocyte-derived dendritic cells and monocyte-derived Langerhans'-like cells. Immunology. 2011, 132 (2): 217-225. 10.1111/j.1365-2567.2010.03356.x.CrossRefPubMedPubMedCentral
16.
Yu HR, Chen RF, Hong KC, Bong CN, Lee WI, Kuo HC, Yang KD: IL-12-independent Th1 polarization in human mononuclear cells infected with varicella-zoster virus. Eur J Immunol. 2005, 35 (12): 3664-3672. 10.1002/eji.200526258.CrossRefPubMed
17.
Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE, Freedman VH, Kaplan G: Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc Natl Acad Sci USA. 2001, 98 (10): 5752-5757. 10.1073/pnas.091096998.CrossRefPubMedPubMedCentral
18.
Cousens LP, Peterson R, Hsu S, Dorner A, Altman JD, Ahmed R, Biron CA: Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J Exp Med. 1999, 189 (8): 1315-1328. 10.1084/jem.189.8.1315.CrossRefPubMedPubMedCentral
19.
Kumar H, Kawai T, Akira S: Pathogen recognition by the innate immune system. Int Rev Immunol. 2011, 30 (1): 16-34. 10.3109/08830185.2010.529976.CrossRefPubMed
20.
Katashiba Y, Miyamoto R, Hyo A, Shimamoto K, Murakami N, Ogata M, Amakawa R, Inaba M, Nomura S, Fukuhara S, et al: Interferon-alpha and interleukin-12 are induced, respectively, by double-stranded DNA and single-stranded RNA in human myeloid dendritic cells. Immunology. 2011, 132 (2): 165-173. 10.1111/j.1365-2567.2010.03350.x.CrossRefPubMedPubMedCentral
21.
Ito T, Amakawa R, Kaisho T, Hemmi H, Tajima K, Uehira K, Ozaki Y, Tomizawa H, Akira S, Fukuhara S: Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med. 2002, 195 (11): 1507-1512. 10.1084/jem.20020207.CrossRefPubMedPubMedCentral
22.
Palmer DR, Sun P, Celluzzi C, Bisbing J, Pang S, Sun W, Marovich MA, Burgess T: Differential effects of dengue virus on infected and bystander dendritic cells. J Virol. 2005, 79 (4): 2432-2439. 10.1128/JVI.79.4.2432-2439.2005.CrossRefPubMedPubMedCentral
23.
Pollara G, Jones M, Handley ME, Rajpopat M, Kwan A, Coffin RS, Foster G, Chain B, Katz DR: Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretion. J Immunol. 2004, 173 (6): 4108-4119.CrossRefPubMed
24.
Ito T, Wang YH, Liu YJ: Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin Immunopathol. 2005, 26 (3): 221-229. 10.1007/s00281-004-0180-4.CrossRefPubMed
25.
Roses RE, Xu S, Xu M, Koldovsky U, Koski G, Czerniecki BJ: Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists. J Immunol. 2008, 181 (7): 5120-5127.CrossRefPubMed
26.
Rutella S, Danese S, Leone G: Tolerogenic dendritic cells: cytokine modulation comes of age. Blood. 2006, 108 (5): 1435-1440. 10.1182/blood-2006-03-006403.CrossRefPubMed
27.
Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 1995, 182 (2): 389-400. 10.1084/jem.182.2.389.CrossRefPubMed
28.
Jalili A: Dendritic cells and their role in cancer immunotherapy. Iran J Immunol. 2007, 4 (3): 127-144.PubMed
29.
Larsson K, Lindstedt M, Borrebaeck CA: Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells. Immunology. 2006, 117 (2): 156-166. 10.1111/j.1365-2567.2005.02274.x.CrossRefPubMedPubMedCentral
30.
Chen RF, Yeh WT, Yang MY, Yang KD: A model of the real-time correlation of viral titers with immune reactions in antibody-dependent enhancement of dengue-2 infections. FEMS Immunol Med Microbiol. 2001, 30 (1): 1-7. 10.1111/j.1574-695X.2001.tb01542.x.CrossRefPubMed
31.
Guzman MG: Global voices of science. Deciphering dengue: the Cuban experience. Science. 2005, 309 (5740): 1495-1497. 10.1126/science.1115177.CrossRefPubMed
32.
Yang KD, Yeh WT, Yang MY, Chen RF, Shaio MF: Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production. J Med Virol. 2001, 63 (2): 150-157. 10.1002/1096-9071(20000201)63:2<150::AID-JMV1010>3.0.CO;2-A.CrossRefPubMed
33.
Chen RF, Liu JW, Yeh WT, Wang L, Chang JC, Yu HR, Cheng JT, Yang KD: Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol. 2005, 44 (1): 43-50. 10.1016/j.femsim.2004.11.012.CrossRefPubMed
34.
Nagahara Y, Nagamori T, Tamegai H, Hitokuwada M, Yoshimi Y, Ikekita M, Shinomiya T: Inulin stimulates phagocytosis of PMA-treated THP-1 macrophages by involvement of PI3-kinases and MAP kinases. Biofactors. 2011, 37 (6): 447-454. 10.1002/biof.186.CrossRefPubMed
35.
Barilli A, Rotoli BM, Visigalli R, Bussolati O, Gazzola GC, Dall'Asta V: Arginine transport in human monocytic leukemia THP-1 cells during macrophage differentiation. J Leukoc Biol. 2011, 90 (2): 293-303. 10.1189/jlb.0910510.CrossRefPubMed
36.
Maess MB, Sendelbach S, Lorkowski S: Selection of reliable reference genes during THP-1 monocyte differentiation into macrophages. BMC Mol Biol. 2010, 11: 90-10.1186/1471-2199-11-90.CrossRefPubMedPubMedCentral
37.
Traore K, Trush MA, George M, Spannhake EW, Anderson W, Asseffa A: Signal transduction of phorbol 12-myristate 13-acetate (PMA)-induced growth inhibition of human monocytic leukemia THP-1 cells is reactive oxygen dependent. Leuk Res. 2005, 29 (8): 863-879. 10.1016/j.leukres.2004.12.011.CrossRefPubMed
38.
Bremner TA, D'Costa N, Dickson LA, Asseffa A: A decrease in glucose 6-phosphate dehydrogenase activity and mRNA is an early event in phorbol ester-induced differentiation of thp-1 promonocytic leukemia cells. Life Sci. 1996, 58 (12): 1015-1022. 10.1016/0024-3205(96)00050-1.CrossRefPubMed
39.
Boonnak K, Dambach KM, Donofrio GC, Tassaneetrithep B, Marovich MA: Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J Virol. 2011, 85 (4): 1671-1683. 10.1128/JVI.00220-10.CrossRefPubMed
40.
Chareonsirisuthigul T, Kalayanarooj S, Ubol S: Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol. 2007, 88 (Pt 2): 365-375.CrossRefPubMed
41.
Wang L, Chen RF, Liu JW, Lee IK, Lee CP, Kuo HC, Huang SK, Yang KD: DC-SIGN (CD209) Promoter −336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation. PLoS Negl Trop Dis. 2011, 5 (1): e934-10.1371/journal.pntd.0000934.CrossRefPubMedPubMedCentral
42.
Chen RF, Wang L, Cheng JT, Chuang H, Chang JC, Liu JW, Lin IC, Yang KD: Combination of CTLA-4 and TGFbeta1 gene polymorphisms associated with dengue hemorrhagic fever and virus load in a dengue-2 outbreak. Clin Immunol. 2009, 131 (3): 404-409. 10.1016/j.clim.2009.01.015.CrossRefPubMed
43.
Wang L, Chen RF, Liu JW, Yu HR, Kuo HC, Yang KD: Implications of dynamic changes among tumor necrosis factor-alpha (TNF-alpha), membrane TNF receptor, and soluble TNF receptor levels in regard to the severity of dengue infection. AmJTrop Med Hyg. 2007, 77 (2): 297-302.
44.
Chen RF, Yang KD, Wang L, Liu JW, Chiu CC, Cheng JT: Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency. Trans R Soc Trop Med Hyg. 2007, 101 (11): 1106-1113. 10.1016/j.trstmh.2007.06.019.CrossRefPubMed
45.
Yeh WT, Chen RF, Wang L, Liu JW, Shaio MF, Yang KD: Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever. FEMS Immunol Med Microbiol. 2006, 48 (1): 84-90. 10.1111/j.1574-695X.2006.00127.x.CrossRefPubMed
46.
Yu HR, Chang JC, Chen RF, Chuang H, Hong KC, Wang L, Yang KD: Different antigens trigger different Th1/Th2 reactions in neonatal mononuclear cells (MNCs) relating to T-bet/GATA-3 expression. J Leukoc Biol. 2003, 74 (5): 952-958. 10.1189/jlb.0902474.CrossRefPubMed
47.
Nudelman G, Ge Y, Hu J, Kumar M, Seto J, Duke JL, Kleinstein SH, Hayot F, Sealfon SC, Wetmur JG: Coregulation mapping based on individual phenotypic variation in response to virus infection. Immunome Res. 2010, 6: 2-10.1186/1745-7580-6-2.CrossRefPubMedPubMedCentral
48.
Pang T, Cardosa MJ, Guzman MG: Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol. 2007, 85 (1): 43-45. 10.1038/sj.icb.7100008.CrossRefPubMed
49.
Friberg H, Bashyam H, Toyosaki-Maeda T, Potts JA, Greenough T, Kalayanarooj S, Gibbons RV, Nisalak A, Srikiatkhachorn A, Green S, et al: Cross-Reactivity and Expansion of Dengue-Specific T cells During Acute Primary and Secondary Infections in Humans. Sci Rep. 2011, 1: 51-CrossRefPubMedPubMedCentral
50.
51.
Pawitan JA: Dengue virus infection: predictors for severe dengue. Acta Med Indones. 2011, 43 (2): 129-135.PubMed
52.
Restrepo BN, Ramirez RE, Arboleda M, Alvarez G, Ospina M, Diaz FJ: Serum levels of cytokines in two ethnic groups with dengue virus infection. AmJTrop Med Hyg. 2008, 79 (5): 673-677.
53.
Pulendran B: Variegation of the immune response with dendritic cells and pathogen recognition receptors. J Immunol. 2005, 174 (5): 2457-2465.CrossRefPubMed
54.
Rovera G, Ferrero D, Pagliardi GL, Vartikar J, Pessano S, Bottero L, Abraham S, Lebman D: Induction of differentiation of human myeloid leukemias by phorbol diesters: phenotypic changes and mode of action. Ann N Y Acad Sci. 1982, 397: 211-220. 10.1111/j.1749-6632.1982.tb43428.x.CrossRefPubMed
55.
Kamiya T, Makino J, Hara H, Inagaki N, Adachi T: Extracellular-superoxide dismutase expression during monocytic differentiation of U937 cells. J Cell Biochem. 2011, 112 (1): 244-255. 10.1002/jcb.22917.CrossRefPubMed
56.
Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH: The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One. 2010, 5 (1): e8668-10.1371/journal.pone.0008668.CrossRefPubMedPubMedCentral
Metadata
Title
Induction of IFNα or IL-12 depends on differentiation of THP-1 cells in dengue infections without and with antibody enhancement
Authors
Rong-Fu Chen
Lin Wang
Jiin-Tsuey Cheng
Kuender D Yang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-340

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue

Research article

Prevalence of smear positive pulmonary tuberculosis among prisoners in North Gondar Zone Prison, northwest Ethiopia

Research article

An expanded age range for meningococcal meningitis: molecular diagnostic evidence from population-based surveillance in Asia

Study protocol

The diagnosis of urinary tract infections in young children (DUTY): protocol for a diagnostic and prospective observational study to derive and validate a clinical algorithm for the diagnosis of UTI in children presenting to primary care with an acute illness

Research article

Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing klebsiella pneumoniaein patients on maintenance hemodialysis

Research article

Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study

Research article

Trends in missed presentations and late HIV diagnosis in a UK teaching hospital: a retrospective comparative cohort study
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits